Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer

被引：0
|
作者：
José Miguel Jurado García
Alfonso Sánchez
Bella Pajares
Elisabeth Pérez
Lorenzo Alonso
Emilio Alba
机构：
[1] Hospital Universitario Virgen de la Victoria,Medical Oncology Service
来源：
Clinical and Translational Oncology | 2008年 / 10卷
关键词：
Ovarian cancer; Platinum resistant; Bevacizumab; Metronomic cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Oral etoposide (VP-16) in heavily pre-treated metastatic breast cancer: A multicenter national observational study
    Lerebours, Florence
    Carton, Matthieu
    Bacrie, Joy
    Pierga, Jean-Yves
    Rouzier, Roman
    Saghatchian, Mahasti
    Dalenc, Florence
    Mailliez, Audrey
    Levy, Christelle
    Firmin, Nelly
    Debled, Marc
    Leheurteur, Marianne
    Desmoulins, Isabelle
    Lefeuvre, Claudia
    Goncalves, Anthony
    Uwer, Lionel
    Ferrero, Jean-Marc
    Eymard, Jean-Christophe
    Petit, Thierry
    Mouret-Reynier, Marie-Ange
    Piot, Irwin
    Perrocheau, Genevieve
    Caillot, Christian
    Perol, David
    CANCER RESEARCH, 2018, 78 (04)
  • [42] A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
    Hu, Nanlin
    Zhu, Anjie
    Si, Yiran
    Yue, Jian
    Wang, Xue
    Wang, Jiayu
    Ma, Fei
    Xu, Binghe
    Yuan, Peng
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [43] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies
    Robak, T
    Góra-Tybor, J
    Lech-Maranda, E
    Blonski, JZ
    Robak, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (03) : 188 - 194
  • [44] Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
    Maria Antonietta De Ioris
    Francesco Fabozzi
    Francesca Del Bufalo
    Giada Del Baldo
    Maria Felicia Villani
    Maria Giuseppina Cefalo
    Maria Carmen Garganese
    Alessandra Stracuzzi
    Federica Tangari
    Arturo Maria Greco
    Isabella Giovannoni
    Roberto Carta
    Maria Luisa D’Andrea
    Angela Mastronuzzi
    Franco Locatelli
    Scientific Reports, 13
  • [45] Lenolidamide (Revlimid), in combination with cyclophosphamide and dexamethasone (CRD) is an effective regimen for heavily pre-treated myeloma patients.
    Morgan, Gareth J.
    Schey, Stephen
    Wu, Ping
    Srikanth, M.
    Phekoo, Karen J.
    Jenner, Matthew W.
    Dines, Sharon
    Saso, Radovan
    Davies, Faith E.
    BLOOD, 2006, 108 (11) : 1015A - 1015A
  • [46] Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
    S Glaysher
    F G Gabriel
    P Johnson
    M Polak
    L A Knight
    K Parker
    M Poole
    A Narayanan
    I A Cree
    British Journal of Cancer, 2010, 103 : 656 - 662
  • [47] Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Miano, Salvatora Tindara
    Marrelli, Daniele
    Roviello, Franco
    Bianco, Vincenzo
    Francini, Edoardo
    FUTURE ONCOLOGY, 2015, 11 (18) : 2563 - 2574
  • [48] COMBINATION THERAPY OF ORAL CYCLOPHOSPHAMIDE AND BEVACIZUMAB FOR PATIENTS WITH RECURRENT OVARIAN AND PERITONEAL CANCER
    Goto, M.
    Takimoto, Y.
    Isono, R.
    Yamashita, M.
    Onoue, M.
    Yoshioka, E.
    Tashima, R.
    Hori, K.
    Tsubamoto, H.
    Ito, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A126 - A126
  • [49] Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
    Gabriella Ferrandina
    Giacomo Corrado
    Floriana Mascilini
    Paola Malaguti
    Riccardo Samaritani
    Mariagrazia Distefano
    Valeria Masciullo
    Alessia Di Legge
    Antonella Savarese
    Giovanni Scambia
    BMC Cancer, 14
  • [50] Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
    De Ioris, Maria Antonietta
    Fabozzi, Francesco
    Del Bufalo, Francesca
    Del Baldo, Giada
    Villani, Maria Felicia
    Cefalo, Maria Giuseppina
    Garganese, Maria Carmen
    Stracuzzi, Alessandra
    Tangari, Federica
    Greco, Arturo Maria
    Giovannoni, Isabella
    Carta, Roberto
    D'Andrea, Maria Luisa
    Mastronuzzi, Angela
    Locatelli, Franco
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345